Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-06-27 to 2024-06-28
Current total value of award: $31092.45
Description: 4565020589!XELJANZ XR 11 MG TABLET UU 30S